These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 23170127)
1. Simultaneous transurethral resection of bladder cancer and prostate may reduce recurrence rates: A systematic review and meta-analysis. Li S; Zeng XT; Ruan XL; Wang XH; Guo Y; Yang ZH Exp Ther Med; 2012 Oct; 4(4):685-692. PubMed ID: 23170127 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the clinical efficacy of simultaneous transurethral resection of both bladder cancer and the prostate: a systematic review and meta-analysis. Zhou L; Liang X; Zhang K Aging Male; 2020 Dec; 23(5):1182-1193. PubMed ID: 32020826 [TBL] [Abstract][Full Text] [Related]
3. Does simultaneous transurethral resection of bladder tumor and prostate affect the recurrence of bladder tumor? A meta-analysis. Luo S; Lin Y; Zhang W J Endourol; 2011 Feb; 25(2):291-6. PubMed ID: 20977373 [TBL] [Abstract][Full Text] [Related]
4. Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2021; 21(12):1-123. PubMed ID: 34484486 [TBL] [Abstract][Full Text] [Related]
5. The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta-analysis. Sari Motlagh R; Mori K; Miura N; Quhal F; Aydh A; Laukhtina E; Pradere B; Karakiewicz PI; Enikeev DV; Deuker M; Shariat SF BJU Int; 2021 Feb; 127(2):143-152. PubMed ID: 32564458 [TBL] [Abstract][Full Text] [Related]
6. Is it oncologically safe performing simultaneous transurethral resection of the bladder and prostate? A meta-analysis on 1,234 patients. Picozzi SC; Ricci C; Gaeta M; Casellato S; Bozzini G; Ratti D; Carmignani L Int Urol Nephrol; 2012 Oct; 44(5):1325-33. PubMed ID: 22710969 [TBL] [Abstract][Full Text] [Related]
7. Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial. Dellabella M; Branchi A; Gasparri L; Claudini R; Castellani D World J Urol; 2018 Oct; 36(10):1629-1634. PubMed ID: 29725805 [TBL] [Abstract][Full Text] [Related]
8. Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials. Zhou Y; Xue B; Mohammad NA; Chen D; Sun X; Yang J; Dai G Lasers Med Sci; 2016 Apr; 31(3):485-95. PubMed ID: 26868032 [TBL] [Abstract][Full Text] [Related]
9. Blue vs white light for transurethral resection of non-muscle-invasive bladder cancer: an abridged Cochrane Review. Maisch P; Koziarz A; Vajgrt J; Narayan V; Kim MH; Dahm P BJU Int; 2022 Dec; 130(6):730-740. PubMed ID: 35238145 [TBL] [Abstract][Full Text] [Related]
10. Oncological safety of simultaneous transurethral resection of high-grade urothelial carcinoma of the bladder and benign prostatic hyperplasia. Sionov BV; Tsivian M; Bakaleyschik P; Sidi AA; Tsivian A Arab J Urol; 2023; 21(2):102-107. PubMed ID: 37234675 [TBL] [Abstract][Full Text] [Related]
11. Concomitant Endoscopic Surgery for Bladder Tumors and Prostatic Obstruction: Are We Safely Hitting Two Birds with One Stone? A Systematic Review and Meta-Analysis. Savvides E; Pyrgidis N; Langas G; Symeonidis EN; Dimitriadis G; Sountoulides P J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294528 [TBL] [Abstract][Full Text] [Related]
12. Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review. Perlis N; Zlotta AR; Beyene J; Finelli A; Fleshner NE; Kulkarni GS Eur Urol; 2013 Sep; 64(3):421-30. PubMed ID: 23830475 [TBL] [Abstract][Full Text] [Related]
13. A Systematic Review and Meta-Analysis Protocol of Chemoablation vs. Transurethral Resection of Bladder Tumor in Patients With Non-Muscle-Invasive Bladder Cancer. Shi X; Feng D; Wei W Front Surg; 2021; 8():753547. PubMed ID: 34869561 [No Abstract] [Full Text] [Related]
14. The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis. Krajewski W; Nowak Ł; Poletajew S; Tukiendorf A; Moschini M; Mari A; Di Trapani E; Xylinas E; Kiełb P; Wełna M; Zdrojowy R J Endourol; 2020 Aug; 34(8):795-804. PubMed ID: 32336149 [No Abstract] [Full Text] [Related]
15. Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized Trial. Gallagher K; Bhatt N; Clement K; Zimmermann E; Khadhouri S; MacLennan S; Kulkarni M; Gaba F; Anbarasan T; Asif A; Light A; Ng A; Chan V; Nathan A; Cooper D; Aucott L; Marcq G; Teoh JY; Hensley P; Duncan E; Goulao B; O'Brien T; Nielsen M; Mariappan P; Kasivisvanathan V JMIR Res Protoc; 2023 Jun; 12():e42254. PubMed ID: 37318875 [TBL] [Abstract][Full Text] [Related]
16. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311 [TBL] [Abstract][Full Text] [Related]
17. Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study. Jaidane M; Bouicha T; Slama A; Hmida W; Hidoussi A; Ben Sorba N; Mosbah F Urology; 2010 Jun; 75(6):1392-5. PubMed ID: 19781747 [TBL] [Abstract][Full Text] [Related]
18. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study). Miyake M; Nishimura N; Inoue T; Suzuki S; Fujii T; Owari T; Hori S; Nakai Y; Toritsuka M; Nakagawa H; Tsukamoto S; Anai S; Torimoto K; Yoneda T; Tanaka N; Fujimoto K Trials; 2021 Feb; 22(1):136. PubMed ID: 33579327 [TBL] [Abstract][Full Text] [Related]
19. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526 [TBL] [Abstract][Full Text] [Related]
20. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer. Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]